Furthermore, CD133- lung cancer cells with forced snoRA42 expression have the capacity to enhance the in vitro tumorigenicity, whereas the CD133- cells without forced snoRA42 expression do not. This evidence concerns the gene SNORA80E and lung carcinoma.